AT
LLY icon

Arvest Trust’s Eli Lilly LLY Stock Holding History

Arvest Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$469K Sell
518
-37
-7% -$29.6K 0.03% 119
2024
Q1 		$432K Sell
555
-80
-13% -$56.9K 0.02% 129
2023
Q4 		$370K Buy
635
+207
+48% +$121K 0.02% 137
2023
Q3 		$230K Buy
+428
New +$221K 0.02% 146
2022
Q2 		– Sell
-1,901
Closed -$544K – 162
2022
Q1 		$544K Buy
1,901
+159
+9% +$40.9K 0.03% 117
2021
Q4 		$481K Buy
+1,742
New +$442K 0.03% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arvest Trust's LLY Position: Q2 2024 in Review

Arvest Trust reduced its Eli Lilly (LLY) stake by 6.7% in Q2 2024, selling an estimated $29.6K and leaving 518 shares worth $469K. The position accounts for 0.03% of the portfolio, ranked #119.

Arvest Trust first reported a position in LLY in Q4 2021 and has held it in 6 quarters since. The position peaked at $544K in Q1 2022. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Arvest Trust held 518 shares of Eli Lilly worth $469K as of Q2 2024.
  • Arvest Trust sold 37 Eli Lilly shares in Q2 2024, an estimated $29.6K.
  • Eli Lilly made up 0.03% of Arvest Trust's portfolio in Q2 2024, its #119 holding.
  • Arvest Trust first reported a position in Eli Lilly in Q4 2021 and has held it in 6 quarters since.
  • Arvest Trust's Eli Lilly position peaked at $544K in Q1 2022.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.